Patent · US Active

Triazolo[4,5-d]pyrimidine derivatives

US9855268B2 · kind B2 · utility

1Cited by

3References

3Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Dieter Dorsch · Ober-Ramstadt, DE
Guenter Hoelzemann · Seeheim-Jugenheim, DE
Michel Calderini · Darmstadt, DE
Ansgar Wegener · Heusenstamm, DE
Oliver Poeschke · Wiesbaden, DE

Key dates

Filing date	Feb 10, 2014
Grant date	Jan 2, 2018
Priority date	—
Expiry date	Feb 10, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula Iin which R1 and R2 have the meanings indicated in claim 1, are inhibitors of GCN2, and can be employed, inter alia, for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.